Biogen Inc. - stock earnings
BIIB Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| June 20, 2024 BeforeMarket | - / - | 2.2 billion | - / 2.3 billion | 2.4 billion |
| July 23, 2024 BeforeMarket | - / - | 2.3 billion | - / 2.4 billion | 2.5 billion |
BIIB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 393.4 million USD | 2.2 billion USD |
| 2023Q4 | 249.7 million USD | 2.4 billion USD |
| 2023Q3 | -68.1 million USD | 2.5 billion USD |
| 2023Q2 | 591.6 million USD | 2.5 billion USD |
| 2023Q1 | 387.9 million USD | 2.5 billion USD |
| 2022Q4 | 550.4 million USD | 2.5 billion USD |
| 2022Q3 | 1.1 billion USD | 2.5 billion USD |
| 2022Q2 | 1.1 billion USD | 2.6 billion USD |
| 2022Q1 | 221.8 million USD | 2.5 billion USD |
| 2021Q4 | 368.2 million USD | 2.7 billion USD |
| 2021Q3 | 329.2 million USD | 2.8 billion USD |
| 2021Q2 | 448.5 million USD | 2.8 billion USD |
| 2021Q1 | 410.2 million USD | 2.7 billion USD |
| 2020Q4 | 357.9 million USD | 2.9 billion USD |
| 2020Q3 | 701.5 million USD | 3.4 billion USD |
| 2020Q2 | 1.5 billion USD | 3.7 billion USD |
| 2020Q1 | 1.4 billion USD | 3.5 billion USD |
| 2019Q4 | 1.4 billion USD | 3.7 billion USD |
| 2019Q3 | 1.5 billion USD | 3.6 billion USD |
| 2019Q2 | 1.5 billion USD | 3.6 billion USD |
| 2019Q1 | 1.4 billion USD | 3.5 billion USD |
| 2018Q4 | 946.8 million USD | 3.5 billion USD |
| 2018Q3 | 1.4 billion USD | 3.4 billion USD |
| 2018Q2 | 866.6 million USD | 3.4 billion USD |
| 2018Q1 | 1.2 billion USD | 3.1 billion USD |
| 2017Q4 | -297.4 million USD | 3.3 billion USD |
| 2017Q3 | 1.2 billion USD | 3.1 billion USD |
| 2017Q2 | 862.8 million USD | 3.1 billion USD |
| 2017Q1 | 747.6 million USD | 2.8 billion USD |
| 2016Q4 | 649.2 million USD | 2.9 billion USD |
| 2016Q3 | 1.0 billion USD | 3.0 billion USD |
| 2016Q2 | 1.0 billion USD | 2.9 billion USD |
| 2016Q1 | 970.9 million USD | 2.7 billion USD |
| 2015Q4 | 831.6 million USD | 2.8 billion USD |
| 2015Q3 | 965.6 million USD | 2.8 billion USD |
| 2015Q2 | 927.3 million USD | 2.6 billion USD |
| 2015Q1 | 822.5 million USD | 2.6 billion USD |
| 2014Q4 | 883.5 million USD | 2.6 billion USD |
| 2014Q3 | 856.9 million USD | 2.5 billion USD |
| 2014Q2 | 714.5 million USD | 2.4 billion USD |
| 2014Q1 | 480.0 million USD | 2.1 billion USD |
| 2013Q4 | 457.3 million USD | 2.0 billion USD |
| 2013Q3 | 487.6 million USD | 1.8 billion USD |
| 2013Q2 | 490.7 million USD | 1.7 billion USD |
| 2013Q1 | 426.7 million USD | 1.4 billion USD |
| 2012Q4 | 292.1 million USD | 1.4 billion USD |
| 2012Q3 | 398.4 million USD | 1.1 billion USD |
| 2012Q2 | 386.8 million USD | 1.4 billion USD |
| 2012Q1 | 302.7 million USD | 1.3 billion USD |
| 2011Q4 | 300.2 million USD | 1.3 billion USD |
| 2011Q3 | 351.8 million USD | 1.3 billion USD |
| 2011Q2 | 288.0 million USD | 1.2 billion USD |
| 2011Q1 | 293.8 million USD | 1.2 billion USD |
| 2010Q4 | 240.3 million USD | 1.2 billion USD |
| 2010Q3 | 254.1 million USD | 1.2 billion USD |
| 2010Q2 | 293.4 million USD | 1.2 billion USD |
| 2010Q1 | 217.0 million USD | 1.1 billion USD |
| 2009Q4 | 305.6 million USD | 1.1 billion USD |
| 2009Q3 | 277.7 million USD | 1.1 billion USD |
| 2009Q2 | 142.8 million USD | 1.1 billion USD |
| 2009Q1 | 244.0 million USD | 1.0 billion USD |
| 2008Q4 | 206.7 million USD | 1.1 billion USD |
| 2008Q3 | 206.8 million USD | 1.1 billion USD |
| 2008Q2 | 206.3 million USD | 993.4 million USD |
| 2008Q1 | 163.4 million USD | 942.2 million USD |
| 2007Q4 | 201.2 million USD | 893.3 million USD |
| 2007Q3 | 119.6 million USD | 789.2 million USD |
| 2007Q2 | 185.9 million USD | 773.2 million USD |
| 2007Q1 | 131.7 million USD | 715.9 million USD |
| 2006Q4 | 108.6 million USD | -102.5 million USD |
| 2006Q3 | 156.8 million USD | 703.5 million USD |
| 2006Q2 | -170.6 million USD | 660.0 million USD |
| 2006Q1 | 122.8 million USD | 611.2 million USD |
| 2005Q4 | 55.6 million USD | -76.0 million USD |
| 2005Q3 | 27.1 million USD | 596.2 million USD |
| 2005Q2 | 34.5 million USD | 605.6 million USD |
| 2005Q1 | 43.4 million USD | 587.8 million USD |
| 2004Q4 | 28.7 million USD | -28.0 million USD |
| 2004Q3 | 36.7 million USD | 543.3 million USD |
| 2004Q2 | 826000 USD | 538.8 million USD |
| 2004Q1 | -41.2 million USD | 541.7 million USD |
| 2003Q4 | -1.1 billion USD | -308.9 million USD |
| 2003Q3 | 44.9 million USD | 341.8 million USD |
| 2003Q2 | 57.9 million USD | 325.6 million USD |
| 2003Q1 | 63.5 million USD | 320.7 million USD |
| 2002Q4 | 41.4 million USD | 302.4 million USD |
| 2002Q3 | 42.2 million USD | 288.3 million USD |
| 2002Q2 | 43.4 million USD | 269.3 million USD |
| 2002Q1 | 58.9 million USD | 280.5 million USD |
| 2001Q4 | 58.9 million USD | 280.5 million USD |
| 2001Q3 | 69.8 million USD | 265.2 million USD |
| 2001Q2 | 71.9 million USD | 260.7 million USD |
| 2001Q1 | 71.8 million USD | 245.3 million USD |
| 2000Q4 | 71.8 million USD | 245.3 million USD |
| 2000Q3 | 68.4 million USD | 233.8 million USD |
| 2000Q2 | 72.1 million USD | 230.5 million USD |
| 2000Q1 | 121.4 million USD | 216.8 million USD |
| 1999Q4 | 69.4 million USD | 225.3 million USD |
| 1999Q3 | 62.0 million USD | 208.4 million USD |
| 1999Q2 | 43.4 million USD | 188.9 million USD |
| 1999Q1 | 45.7 million USD | 171.7 million USD |
| 1998Q4 | 41.9 million USD | 168.4 million USD |
| 1998Q3 | 37.6 million USD | 145.9 million USD |
| 1998Q2 | 31.4 million USD | 128.8 million USD |
| 1998Q1 | 27.8 million USD | 114.5 million USD |
| 1997Q4 | 31.8 million USD | 146.1 million USD |
| 1997Q3 | 20.5 million USD | 100.6 million USD |
| 1997Q2 | 19.9 million USD | 92.4 million USD |
| 1997Q1 | 17.0 million USD | 94.8 million USD |
| 1996Q4 | 8.2 million USD | 104.8 million USD |
| 1996Q3 | 1.1 million USD | 33.9 million USD |
| 1996Q2 | -9.1 million USD | 41.2 million USD |
| 1996Q1 | 960000 USD | 53.1 million USD |
| 1995Q4 | 960000 USD | 53.1 million USD |
| 1995Q3 | 1.1 million USD | 33.9 million USD |
| 1995Q2 | 700000 USD | 32.7 million USD |
| 1995Q1 | 2.8 million USD | 32.0 million USD |
| 1994Q4 | 9.7 million USD | 42.9 million USD |
| 1994Q3 | -26.4 million USD | 31.8 million USD |
| 1994Q2 | 600000 USD | 32.8 million USD |
| 1994Q1 | 11.2 million USD | 41.2 million USD |
| 1993Q4 | 4.2 million USD | 35.2 million USD |
| 1993Q3 | 11.3 million USD | 33.9 million USD |
| 1993Q2 | 5.6 million USD | 34.7 million USD |
| 1993Q1 | 11.3 million USD | 32.5 million USD |
| 1992Q4 | 25.7 million USD | 51.5 million USD |
| 1992Q3 | 11.1 million USD | 37.9 million USD |
| 1992Q2 | 700000 USD | 18.1 million USD |
| 1992Q1 | 800000 USD | 16.1 million USD |
| 1991Q4 | 1.0 million USD | 15.4 million USD |
| 1991Q3 | 1.0 million USD | 14.8 million USD |
| 1991Q2 | 2.3 million USD | 15.3 million USD |
| 1991Q1 | 2.9 million USD | 15.9 million USD |
| 1990Q4 | 2.6 million USD | 13.8 million USD |
| 1990Q3 | 1.8 million USD | 12.5 million USD |
| 1990Q2 | 1.6 million USD | 12.0 million USD |
| 1990Q1 | 1.7 million USD | 11.8 million USD |
| 1989Q4 | 1.6 million USD | 7.5 million USD |
| 1989Q3 | 1.7 million USD | 7.0 million USD |
| 1989Q2 | -200000 USD | 6.9 million USD |
| 1989Q1 | 100000 USD | 8.1 million USD |
| 1988Q4 | 200000 USD | 5.6 million USD |
| 1988Q3 | 400000 USD | 3.6 million USD |
| 1988Q2 | -900000 USD | 5.8 million USD |
| 1988Q1 | -900000 USD | 5.6 million USD |
| 1987Q4 | -3.4 million USD | 1.8 million USD |
| 1987Q3 | -7.0 million USD | 1.8 million USD |
| 1987Q2 | -6.6 million USD | 1.7 million USD |
| 1987Q1 | -5.6 million USD | 3.2 million USD |
| 1986Q4 | -7.7 million USD | 800000 USD |
| 1986Q3 | -7.5 million USD | 700000 USD |
| 1986Q2 | -6.7 million USD | 2.0 million USD |
| 1986Q1 | -6.3 million USD | 2.8 million USD |
| 1985Q4 | -6.5 million USD | 2.9 million USD |
| 1985Q3 | -4.8 million USD | 4.0 million USD |
BIIB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.2 billion USD | 9.8 billion USD |
| 2022 | 3.0 billion USD | 10.2 billion USD |
| 2021 | 1.6 billion USD | 11.0 billion USD |
| 2020 | 4.0 billion USD | 13.4 billion USD |
| 2019 | 5.9 billion USD | 14.4 billion USD |
| 2018 | 4.4 billion USD | 13.5 billion USD |
| 2017 | 2.5 billion USD | 12.3 billion USD |
| 2016 | 3.7 billion USD | 11.4 billion USD |
| 2015 | 3.5 billion USD | 10.8 billion USD |
| 2014 | 2.9 billion USD | 9.7 billion USD |
| 2013 | 1.9 billion USD | 6.9 billion USD |
| 2012 | 1.4 billion USD | 5.5 billion USD |
| 2011 | 1.2 billion USD | 5.0 billion USD |
| 2010 | 1.0 billion USD | 4.7 billion USD |
| 2009 | 970.1 million USD | 4.4 billion USD |
| 2008 | 783.2 million USD | 4.1 billion USD |
| 2007 | 638.2 million USD | 3.2 billion USD |
| 2006 | 217.5 million USD | 1.9 billion USD |
| 2005 | 160.7 million USD | 1.7 billion USD |
| 2004 | 25.1 million USD | 1.6 billion USD |
| 2003 | -875.1 million USD | 679.2 million USD |
| 2002 | 199.1 million USD | 1.1 billion USD |
| 2001 | 272.7 million USD | 1.0 billion USD |
| 2000 | 333.6 million USD | 926.5 million USD |
| 1999 | 220.5 million USD | 794.4 million USD |
| 1998 | 138.7 million USD | 557.6 million USD |
| 1997 | 89.2 million USD | 434.0 million USD |
| 1996 | 40.5 million USD | 277.1 million USD |
| 1995 | 5.7 million USD | 151.7 million USD |
| 1994 | -4.9 million USD | 156.3 million USD |
| 1993 | 32.4 million USD | 136.4 million USD |
| 1992 | 38.3 million USD | 123.7 million USD |
| 1991 | 7.2 million USD | 61.4 million USD |
| 1990 | 7.7 million USD | 50.1 million USD |
| 1989 | 3.2 million USD | 28.5 million USD |
| 1988 | -1.2 million USD | 20.6 million USD |
| 1987 | -22.6 million USD | 8.6 million USD |
| 1986 | -28.2 million USD | 6.4 million USD |
| 1985 | -19.1 million USD | 15.1 million USD |
BIIB
Price: $216.13
52 week price:
Earnings Per Share: 7.97 USD
P/E Ratio: 24.23
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 789100
Ebitda: 1.6 billionMarket Capitalization: 31.3 billion